Fundz

Omnicure Inc. reported raising $300,000 in an initial SEC Form D filing, from an offering of $680,000

PRIVATESep 07, 2017$300K of $680K raised

Amount Raised

$300,000

$300,000 sold, per SEC Form D (first sale Sep 7, 2017)

Round Type

Seed

PittsburghManufacturingBiotechnologyArtificial Intelligence

Quick answer

Excelitas raised $300,000 in a Seed round, dated September 7, 2017. Excelitas is based in Pittsburgh, Pennsylvania, United States.

How much did Excelitas raise?
Excelitas raised $300,000 in a Seed round on September 7, 2017.
What does Excelitas do?
Excelitas is a leading provider of advanced, life-enriching technologies that make a difference, serving global market leaders in the life sciences, advanced industrial, next-generation semiconductor and avionics end..
Where is Excelitas based and how big is it?
Excelitas is based in Pittsburgh, Pennsylvania, United States.
Who are the decision-makers at Excelitas?
Fundz holds 1 contact at Excelitas. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Excelitas that raised within 45 days of this round, from Fundz verified event records.

  • DetraPel raised $70K (Pre-Seed) on October 6, 2017.
  • Recursion Pharmaceuticals raised $56M on October 6, 2017.
  • Avenda Health, Inc. raised $350K (Seed) on September 28, 2017.
  • Flyte Aviation, Inc. raised $650K (Seed) on September 20, 2017.
  • USBC raised $150K (Seed) on September 15, 2017.
  • Neochord raised $4M (Seed) on September 12, 2017.

Who to call at Excelitas, and when

A new round usually means Excelitas is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Excelitas raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Excelitas, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Excelitas. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Excelitas

Location

2545 Railroad Street, Suite 300

Pittsburgh, Pennsylvania, United States

About

Excelitas is a leading provider of advanced, life-enriching technologies that make a difference, serving global market leaders in the life sciences, advanced industrial, next-generation semiconductor and avionics end markets. It is at the forefront of addressing many relevant megatrends impacting the world today, including precision medicine, industrial automation, and artificial intelligence.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Excelitas raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Excelitas's next move

See what Strategic adds

Excelitas raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.